A Need for Speed? Bypass Time and Outcomes after Isolated Aortic Valve Replacement Surgery
OBJECTIVES:
To determine in the modern era if
cardiopulmonary bypass (CPB) time has a significant effect on
postoperative morbidity, mortality and long-term survival in patients
undergoing isolated aortic valve replacement (AVR) surgery.
METHODS:
Analysis
of a prospectively collected cardiac surgery database was performed.
Uni- and multivariate analysis on the need of resternotomy for bleeding,
mediastinal blood loss, intensive care unit (ICU) length of stay,
hospital length of stay, in-hospital mortality and long- term survival
was performed. Only patients with a cross-clamp time <90 min were
analysed to exclude technical issues confounding the results.
RESULTS:
A
total of 1863 isolated first-time AVR procedures were analysed, with an
in-hospital mortality rate of 2.4%. The rate of long-term follow-up
achieved was 100%. Univariate analysis revealed that CPB time (minutes)
had no significant effect on resternotomy (P = 0.5), creatinine kinase
muscle-brain isoenzyme (CKMB) release (P = 0.8) and long-term survival
(P = 0.06), but was significantly associated with mediastinal blood loss
(P = 0.01), ICU length of stay (P = 0.02), hospital length of stay (P =
0.03) and in-hospital mortality (P < 0.001). Multivariate analysis
identified that bypass time (min) was a significant factor associated
with mediastinal blood loss (P < 0.001), ICU length of stay (P =
0.01), postoperative length of stay (P < 0.001) and in-hospital
mortality (odds ratio [OR] 1.02, 95% CI 1.01-1.04, P = 0.01), but not
long-term survival. Multivariate analysis identified that era of surgery
had no significant effect on CKMB release (P = 0.2), mediastinal blood
loss (P = 0.4) and in-hospital mortality (P = 0.9), but the latter era
of this study was significantly associated with a reduced postoperative
length of stay (P < 0.001), reduced ICU length of stay (P <
0.001), reduced need for resternotomy for bleeding (OR 0.62, 95% CI
0.41-0.94, P = 0.02) and improved long-term survival (hazard ratio 0.76,
95% CI 0.59-0.96, P = 0.02). Adjusting for era made no difference with
respect to the above study findings.
CONCLUSIONS:
Despite
improvements over time with regard to morbidity, mortality and
long-term survival, CPB time remains a significant factor determining
mediastinal blood loss, ICU and hospital length of stay, and in-hospital
mortality.